Skip to main content
HLB Therapeutics Co.,Ltd. logo

HLB Therapeutics Co.,Ltd. — Investor Relations & Filings

Ticker · 115450 ISIN · KR7115450009 KO Manufacturing
Filings indexed 443 across all filing types
Latest filing 2018-11-12 Major Shareholding Noti…
Country KR South Korea
Listing KO 115450

About HLB Therapeutics Co.,Ltd.

https://hlbtherapeutics.co.kr/en/

HLB Therapeutics Co., Ltd. is a biopharmaceutical company specializing in the development of innovative, first-in-class drugs for rare and intractable diseases. The company's clinical-stage pipeline focuses on addressing unmet medical needs in ophthalmology and oncology. Key development programs include RGN-259, a therapeutic agent for Dry Eye Disease and Neurotrophic Keratopathy, and OKN-007 for the treatment of Glioblastoma Multiforme. Additionally, the company is advancing a Natural Killer (NK) cell therapy through late-stage clinical trials to provide new therapeutic options for patients.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. This document is used to report significant changes in share ownership (5% rule) and is classified as a Major Shareholding Notification.
2018-11-12 Korean
증권발행결과(자율공시)(제7회차 CB)
Capital/Financing Update Classification · 95% confidence The document is a 'Securities Issuance Result' (증권 발행결과) regarding the issuance of convertible bonds (CB). It details the issuance method, amount, and payment date. This falls under the category of capital structure changes and financing activities, specifically matching the 'Share Issue/Capital Change' (SHA) category as it relates to the issuance of securities.
2018-10-31 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 95% confidence The document is a 'Major Report' (주요사항보고서) filed with the Financial Services Commission/Korea Exchange regarding the issuance of convertible bonds (전환사채권 발행결정). This type of regulatory filing in the Korean market, which details specific capital-raising activities like bond issuance, falls under the 'Capital/Financing Update' category.
2018-10-26 Korean
증권발행결과(자율공시)(제6회차 CB)
Capital/Financing Update Classification · 95% confidence The document is a 'Securities Issuance Result' (증권 발행결과) announcement regarding the issuance of convertible bonds (CB). It details the issuance amount, payment date, and confirms the completion of the transaction. This falls under the category of capital and financing updates, specifically related to the issuance of debt instruments.
2018-10-19 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 98% confidence The document is a 'Major Matters Report' (주요사항보고서) filed with the Financial Services Commission/Korea Exchange regarding the issuance of convertible bonds (전환사채권 발행결정). This document details the terms of the bond, including interest rates, conversion prices, put options, and the list of investors. In the context of Korean corporate filings, this is a standard regulatory disclosure for capital financing activities. Since it details the issuance of new financial instruments (convertible bonds) to raise capital, it falls under the 'Capital/Financing Update' category.
2018-10-17 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. This document is used to report significant changes in share ownership (crossing thresholds or changes in purpose). It contains detailed tables regarding the reporter, special relations, shareholding ratios, and contract details. This falls under the 'Major Shareholding Notification' category.
2018-10-12 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.